TOT BIOPHARM International Co. Ltd. ( (HK:1875) ) has issued an announcement.
TOT BIOPHARM International Co. Ltd. has announced that its board of directors will meet on March 11, 2025, to review and approve the company’s annual results for the year ending December 31, 2024. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
More about TOT BIOPHARM International Co. Ltd.
TOT BIOPHARM International Co. Ltd. is a company incorporated in Hong Kong, operating within the biopharmaceutical industry. It focuses on the development, manufacturing, and commercialization of oncology drugs and therapies.
YTD Price Performance: 2.74%
Average Trading Volume: 47,786
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$1.42B
See more insights into 1875 stock on TipRanks’ Stock Analysis page.